Prøve GULL - Gratis
Middle East Leverages AI for Real Gains
BioSpectrum Asia
|BioSpectrum Asia Oct 2025
The Middle East is not only investing in digital healthcare, but building around it. From national health strategies to growing startup hubs, the region is turning infrastructure gaps into launch pads. With a projected compound annual growth rate (CAGR) of 9.2 per cent, the Middle East's digital healthcare market is poised to reach $7.9 billion by 2028. Moreover, the United Arab Emirates (UAE) has now launched a strategic initiative aimed at strengthening its position as a leading global hub for entrepreneurship and innovation, especially with the advent of artificial intelligence (AI) and other technologies. But there are certain barriers affecting technology adoption and startup scale-up in the region. Let's look into this in detail.
The Middle East is not only investing in digital healthcare, but building around it. From national health strategies to growing startup hubs, the region is turning infrastructure gaps into launch pads. With a projected compound annual growth rate (CAGR) of 9.2 per cent, the Middle East's digital healthcare market is poised to reach $7.9 billion by 2028. Moreover, the United Arab Emirates (UAE) has now launched a strategic initiative aimed at strengthening its position as a leading global hub for entrepreneurship and innovation, especially with the advent of artificial intelligence (AI) and other technologies. But there are certain barriers affecting technology adoption and startup scale-up in the region.
From virtual hospitals to AI-powered diagnostics, the Middle East is rapidly becoming one of the world's most dynamic frontiers for digital health. Governments across the region are making bold investments in healthcare innovation. For instance, Saudi Arabia's healthcare ambitions under Vision 2030 have positioned the Kingdom as a global leader in digital health. The kingdom established the Saudi Data & AI Authority (SDAIA) to steer AI policy and launched a national strategy to develop AI and data capabilities. Saudi Arabia has set targets like creating 300 AI-driven startups and attracting $20 billion in AI investments by 2030. Also, Saudi's HUMAIN (a Public Investment Fund-backed AI company) plans a $10 billion venture fund to fuel AI startups.
Denne historien er fra BioSpectrum Asia Oct 2025-utgaven av BioSpectrum Asia.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA BioSpectrum Asia
BioSpectrum Asia
Kyorin and Lunatus partner to launch Lasvic tablets in 9 Middle Eastern countries
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulting FZCO for Lasvic tablets (Lascufloxacin hydrochloride).
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
Australia-based Vaxxas has announced the appointment of global biopharmaceutical executive David Peacock as Chief Executive Officer (CEO) to lead the commercialisation of the company's proprietary high-density microarray patch (HD-MAP) vaccination technology.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Thermo Fisher partners with NVIDIA leveraging AI to advance scientific instrumentation
US-based Thermo Fisher Scientific Inc. has announced a strategic collaboration with NVIDIA to power artificial intelligence (AI)based solutions and laboratory automation at scale.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio
Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bioengineered tissue by Japan emerges as revolutionary treatment for secondary lymphedema
A research team led by Associate Professor Kosuke Kusamori from the Faculty of Pharmaceutical Sciences at Tokyo University of Science (TUS), Japan, is pioneering an innovative technique for lymphatic tissue engineering that could revolutionize the treatment of secondary lymphedema.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Chitose and Fujifilm Biosciences to drive global innovation and biopharma manufacturing
Japan-based Chitose Laboratory Corp. & Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vibrant Therapeutics on-boards Dr Han Lee as Co-CEO
Vibrant Therapeutics, a clinical-stage biotechnology company based in China and US, has announced the appointment of Dr Han Lee as co-chief executive officer (CEO).
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
IIT-D and AIIMS develop swallowable microdevice for microbiome study
Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Ambitious research to develop multivalent vaccines against multiple deadly filoviruses
Scientists at the University of Oxford, in collaboration with partners, will spearhead the development of new vaccines that aim to provide comprehensive protection against multiple lethal filoviruses, including Ebola virus, Sudan virus, Bundibugyo virus, and Marburg virus.
1 min
BioSpectrum Asia Feb 2026
Listen
Translate
Change font size

